ATLANTHERA logo — Bone targeted delivery concept

ATLANTHERA

Bone targeted delivery concept

Founded 2011 France France 8 employees Series Unknown Total: $800.00K Health and Wellness

General Information

Company Name ATLANTHERA
Founded Year 2011
Location France France +1
Employees 8
Industries Health and Wellness
Funding Stage Series Unknown
Social

Get notified when ATLANTHERA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ATLANTHERA

ATLANTHERA is a drug discovery company with a focus on bone diseases and bone cancer treatments. The company's slogan is "Bone targeted delivery concept," which aligns with its vision to be the leader in bone-targeted drug delivery to cure bone cancer and metastases. Founded in 2011 and headquartered in France, Atlanthera boasts a highly qualified team and a worldwide-known experts network. Their concept revolves around bone-targeted delivery of anti-cancer drugs. The last investment of €800.00K came in the form of a Venture Round investment on 15 April 2014, with Go Capital being the investor. For more information, visit their website www.atlanthera.com or watch their concept video at https://youtu.be/m3BBWguO6hs.

Taxonomy: Drug Discovery, Therapeutic Approaches, Bone-targeted Drug Delivery, Bone Tumors, Cancer Treatments, Metastases, Research and Development, Oncology, Medical Innovation

Services & Products

Development of novel therapies for bone and joint diseases
custom drug conjugation
targeted drug delivery
drug vectorization

Target Customers

Patients with bone and joint diseases such as osteosarcoma osteoarthritis and bone metastases from various primary cancers oncologists orthopedic specialists

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
15 Apr 2014

ATLANTHERA Alternatives & Competitors

ATLANTHERA vs

Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteo...

24 employees
Biotechnology
ATLANTHERA vs

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and li...

Series Unknown
1 employees
Biotechnology, Life Sciences
ATLANTHERA vs

Enobia develops therapies to treat serious genetic bone disorders for which there are no approved tr...

Series Unknown
8 employees
Biotechnology, Health Care
Also compare with: ATLANTHERA vs ARIZ Precision Medicine ARIZ Precision Medicine

FAQ About ATLANTHERA

Bone targeted delivery concept
ATLANTHERA was founded in 2011.
ATLANTHERA is headquartered in France.
ATLANTHERA operates in the following industries: Health and Wellness.
ATLANTHERA has approximately 8 employees.
ATLANTHERA has completed 1 funding round, raising a total of $800.00K. The latest funding stage is Series Unknown.
ATLANTHERA offers: Development of novel therapies for bone and joint diseases, custom drug conjugation, targeted drug delivery, drug vectorization.
Top alternatives and competitors to ATLANTHERA include ATLANTIC BONE SCREEN, Photobiotics, Enobia Pharma, Thelial Technologies, ApoGen Biotechnologies, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ATLANTHERA and ATLANTIC BONE SCREEN are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ATLANTHERA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy